Dopamine

  • Description and indication for use

    Dopamine is a naturally occurring catecholamine with sympathomimetic actions.  Dopamine acts on both alpha and beta adrenergic receptors as well as peripheral dopamine receptors causing both isotropic and chronotropic responses.

    The isotropic action strengthens the muscle contractibility of the heart and chronotropic action increases heart rate.  The major action of Dopamine is that it causes vasodilatation of renal, coronary, mesenteric and intracerebral beds with little effect on blood pressure or heart rate at low doses.

    Dopamine is used to improve cardiac output, blood pressure and urine output in critically ill patients with hypotension.

    Dose

    Improvement of cardiac output and BP

    IV infusion:        

    2 to 20 mcg/kg/minute.

    Improvement of renal perfusion

    IV infusion:  

    2 to 5 mcg/kg/minute.

    Reconstitution

    Ampoule = 200 mg in 5 mL.

    IV:    

    Withdraw required dose and make up to ordered volume of fluid for infusion via pump.

    Usual order will be as follows:

    Drug How to make up Dose equivalent Dose range
    Dopamine 60 mg/kg in 50 mL glucose 10% 1 mL/hr = 20 micrograms/kg/min 4 - 20 micrograms/kg/min

    Not for IM use.

    Route and method of administration

    IV Infusion:        

    Continuous infusion via syringe pump.

    Administer only into a central line.

    Side effects

    Hypotension/Hypertension.

    Reduced or excessive diuresis.

    Tachycardia.

    GI tract upset.

    Ectopic beats.

    Vasoconstriction.

    Metabolic acidosis.

    Tissue sloughing and necrosis may occur if extravasation of Dopamine occurs at infusion site, due to local vasoconstriction.

    Compatibilities

    Fluids:

    Glucose 5%, Glucose 10%, Sodium chloride 0.9%.

    Drugs:

    Aminophylline, Dobutamine, Glyceryl Trinitrate, Heparin, Hydrocortisone, Potassium Chloride, Ranitidine, Verapamil.

    Via Y-site: 

    Amiodarone, Ciprofloxacin, Dobutamine, Glyceryl Trinitrate, Heparin, Hydrocortisone, Morphine, Potassium Chloride, Ranitidine, Verapamil.

    Incompatibilities

    Fluids:        Sodium Bicarbonate and other alkaline solutions.

    Drugs:        Aciclovir, Ampicillin, Gentamicin, Amphotericin B, Frusemide, Indomethacin, Insulin.

    Administer alone or contact Pharmacy for further information if required.

    Special precautions

    Hypovolaemic states should be corrected prior to Dopamine administration.

    Do not bolus other drugs via Dopamine infusion line.

    Never stop a Dopamine infusion abruptly.

    Contraindications

    Uncorrected tachyarrhythmias.

    Drug interactions

    Phenytoin Administered to patients receiving dopamine may result in severe hypotension and hypovolaemic shock states.  Use with extreme caution.

    Nursing responsibilities

    Continuous blood pressure monitoring preferably with an arterial line.

    Continuously monitor heart rate and rhythm.

    Record vital signs hourly.

    Observe and measure urine output.

    Observe intravenous site for inflammation and extravasation - resite infusion immediately.

    DO NOT GIVE BOLUS DOSES .

    Avoid interruption.

    USE SYRINGE PUMP.

    Change infusion fluid every 24 hours and line every 3 days (as per RCH IV Line Protocol).  When changing syringe and line, ensure 3-way tap is turned off to avoid giving bolus.

    Check that rate ordered corresponds with dose required (micrograms/kg/min).

Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for